IDP.L

InnovaDerma Plc
InnovaDerma PLC - Notice of AGM and Posting of Annual Report
23rd December 2021, 13:22
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 6685W
InnovaDerma PLC
23 December 2021
 

  LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Company")

Notice of Annual General Meeting & Posting of Annual Report and Accounts

 

InnovaDerma (LSE: IDP), a leading digitally focused UK beauty brand developer, announces that it has today posted its Annual Report and Accounts for the year ended 30 June 2021 to shareholders, together with the Notice of the Company's Annual General Meeting ("AGM") and the Form of Proxy. These documents will be available for download on the Company's website, http://www.innovaderma.com/company-publications/.

 

The AGM will be held at TB Cardew, 5 Chancery Lane, London EC4A 1BL on 27 January 2022 at 10 am (GMT).

 

In light of the COVID-19 outbreak, the Board takes the well-being of the Company's employees and Shareholders very seriously. The Government has introduced measures to deal with the coronavirus crisis, which include guidance on social distancing and working from home, which affect the manner in which the Annual General Meeting can be conducted.

 

The Board strongly encourages Shareholders to attend virtually via the Investor Meet Company Platform rather than attend in person, and to vote on all resolutions in advance of the General Meeting by completing their Form of Proxy or submitting their vote via CREST if applicable. Shareholders should appoint the Chair of the General Meeting (and not any named individual) to act as their proxy, to ensure their votes are duly cast.

 

Shareholders are invited to submit any questions for the Board to consider in respect of the business of the AGM.  Questions should be submitted by email by sending them to agminnovaderma@tbcardew.com by 5.00 pm on 14 January 2022 under the title "InnovaDerma Shareholder Questions" and should include any shareholder's full name. A selection of key questions (relating to the business of the AGM) and the Company's responses will be posted on the Company's website by close of business on 19 January 2022 so that shareholders may review these before confirming their proxy vote.

 

In order to ensure that shareholders are able to follow the proceedings of the AGM, the Company will provide access to an online audio and presentation link, accessible via the online Investor Meet Company platform. Shareholders that wish to attend the AGM should register for the event in advance via the following link: https://www.investormeetcompany.com/innovaderma-plc/register-investor.
 

The online presentation link will be opened at approximately 9.55 a.m. on 27 January 2022. However, please note that shareholders will not be able to vote at the AGM via the online presentation link.

 

The Company believes these measures are necessary and appropriate in light of the current pandemic, to protect the health and wellbeing of the Company's employees, shareholders and the wider communities in which we operate.

  Further enquiries

InnovaDerma

Blake Hughes

 

c/o TB Cardew

finncap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

 

Shan Shan Willenbrock/

+ 44 (0)7775 848537

Olivia Rosser

+ 44 (0)7552 864250

 

innovaDerma @ tbcardew.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAMZMZZFFVGMZM ]]>
TwitterFacebookLinkedIn